Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0338671 (
Steroids
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In situ jejunal loops were infused with micellar solutions of cholesterol with or without beta-sitostanol (5 alpha-stigmastan-3 beta-ol), and the uptake of 14C-cholesterol by the loop was followed for 20 minutes. It was found that beta-sitostanol, given as a 'solution-mix' (a solution resulting from the mixture of two separate micellar solutions of cholesterol and beta-sitostanol), at a concentration of 0.30 mM reduced cholesterol uptake. Substituting cholesterol for beta-sitostanol in the 'solution-mix' had no effect on cholesterol uptake by the loop.
beta-Sitostanol
at a concentration of 0.30 mM in the 'pre-mix' (a solution resulting from pre-mixing of the two sterols prior to preparation of the micellar solution) condition, had no effect on cholesterol absorption. Taken together, these results suggest that the concentration of beta-sitostanol-containing micelles is the important factor in its suppression of cholesterol absorption.
Steroids
1980 Dec
PMID:Effect of beta-sitostanol (5 alpha-stigmastan-3 beta-ol) on cholesterol absorption from micellar solutions in jejunal loops in situ. 721 62